Industry

New vendor management system (VMS) delivers smarter, more efficient workforce solutions for health systems SALT LAKE CITY–(BUSINESS WIRE)–CHG Healthcare, the leader in healthcare workforce solutions, announces the launch of Nursesmart, a next-generation vendor management system (VMS) designed specifically for nurse staffing. Nursesmart builds on the proven success of Locumsmart, the #1 physician VMS, which provides … [Read more…]

DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for diseases with high unmet need, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for PBGENE-HBV, the Company’s lead wholly owned in … [Read more…]

‘AI Discovery’ aims to create next generation of AI deeptech founders EDINBURGH, Scotland–(BUSINESS WIRE)–A DeepTech AI initiative has been launched in Scotland to bridge innovation between university postgraduate talent and NHS Scotland. ‘AI Discovery’, delivered by CodeBase via its Techscaler programme in collaboration with the University of Edinburgh, University of Glasgow, and NHS Scotland, will … [Read more…]

Sculptra®, the first proven regenerative biostimulator, will provide new options for patients in China who are looking for innovative treatments to correct mid-facial volume loss and/or contour deficiencies1-7 Sculptra is the only regenerative biostimulator supported by over 25 years of clinical evidence and safety while providing natural-looking results through to two years7-10 Galderma’s journey is … [Read more…]

QUEBEC CITY–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), announces that the Autorité des Marchés Financiers (the “AMF”) has issued a failure to file cease trade order (“FFCTO”) under Policy Statement 11-207 Respecting Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions, prohibiting the trading by any person of any … [Read more…]

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Exicure, Inc. (Nasdaq: XCUR) today announced that GPCR Therapeutics USA, a subsidiary of Exicure Inc., has dosed the 19th patient in its ongoing Phase 2 clinical trial evaluating GPC-100 (burixafor), a small molecule CXCR4 inhibitor, for the mobilization of stem cells in multiple myeloma (MM) patients undergoing autologous stem cell transplant (ASCT) … [Read more…]

FORT WORTH, Texas–(BUSINESS WIRE)–Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the first quarter 2025, before market open on Tuesday, May 6, 2025. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same … [Read more…]

OTTAWA, Ontario–(BUSINESS WIRE)–#ait–For the sixth consecutive year, BioTalent Canada has earned the distinction of being certified as a Great Place to Work®, reinforcing its commitment to building a thriving, diverse, and resilient workforce in Canada’s bio-economy. “To be recognized again as one of Canada’s premier workplaces is a tremendous honour,” says Rob Henderson, President and … [Read more…]

REDWOOD CITY, Calif.–(BUSINESS WIRE)–#cancer—Pheast Therapeutics, a private biotechnology company developing novel therapies to unleash the power of macrophages on aggressive, difficult-to-treat cancers, today announced that the first patient has been treated in its Phase 1 clinical trial evaluating PHST001, an anti-CD24 macrophage checkpoint inhibitor, in patients with advanced solid tumors. “The start of this Phase … [Read more…]

The new test can be used to identify pre-symptomatic patients with Parkinson’s disease and can measure progression of the disease. GREENWICH, Conn. & JERUSALEM–(BUSINESS WIRE)–ATED Therapeutics Ltd. announced a new diagnostic test for Parkinson’s Disease, developed at Hebrew University in Jerusalem, Israel. The test measures transfer RNA fragments (tRF’s) from nucleated red blood cells. Results … [Read more…]